Page last updated: 2024-08-22

magnesium sulfate and Peripheral Nervous System Diseases

magnesium sulfate has been researched along with Peripheral Nervous System Diseases in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atkins, CD	1
Chan, A; Chay, WY; Chiang, J; Lew, KY	1
Al-deeb, AE; Yousef, AA	1
Appenzeller, O; Bicknell, JM; Welch, LK	1

Trials

1 trial(s) available for magnesium sulfate and Peripheral Nervous System Diseases

Article	Year
A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component. Anaesthesia, 2013, Volume: 68, Issue:3 Topics: Administration, Oral; Analgesics; Chronic Disease; Cohort Studies; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Low Back Pain; Lumbar Vertebrae; Magnesium Sulfate; Male; Middle Aged; Neuralgia; Pain; Pain Measurement; Peripheral Nervous System Diseases; Range of Motion, Articular; Treatment Outcome	2013

Article

Year

A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component.

Anaesthesia, 2013, Volume: 68, Issue:3

Topics: Administration, Oral; Analgesics; Chronic Disease; Cohort Studies; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Low Back Pain; Lumbar Vertebrae; Magnesium Sulfate; Male; Middle Aged; Neuralgia; Pain; Pain Measurement; Peripheral Nervous System Diseases; Range of Motion, Articular; Treatment Outcome

2013

Other Studies

3 other study(ies) available for magnesium sulfate and Peripheral Nervous System Diseases

Article	Year
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Oct-10, Volume: 32, Issue:29 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium; Calcium Gluconate; Colonic Neoplasms; Female; Humans; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Peripheral Nervous System Diseases; Sensation Disorders	2014
Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-01, Volume: 29, Issue:16 Topics: Adenocarcinoma; Antineoplastic Agents; Calcium Gluconate; Clinical Trials as Topic; Colonic Neoplasms; Early Termination of Clinical Trials; Humans; Infusions, Intravenous; Magnesium Sulfate; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Research Design; Sensory Receptor Cells	2011
Peripheral neuropathy with myokymia, sustained muscular contraction, and continuous motor unit activity. Neurology, 1972, Volume: 22, Issue:2 Topics: Action Potentials; Adult; Calcium; Decamethonium Compounds; Demyelinating Diseases; Edrophonium; Electromyography; Female; Humans; Magnesium Sulfate; Motor Neurons; Muscle Contraction; Muscles; Muscular Diseases; Neostigmine; Nerve Degeneration; Neural Conduction; Peripheral Nerves; Peripheral Nervous System Diseases; Phenytoin; Tubocurarine	1972